Flow Space on MSN
Update: FDA approves oral version of Wegovy, first GLP-1 pill approved specifically for weight management
Just before the end of 2025, an oral version of a GLP-1 drug specifically used for weight management moved much closer to ...
The changing market is forcing the drugmakers to hire people with more consumer-focused expertise, strike more deals with ...
MedPage Today on MSN
GLP-1 Agents Tied to Less Risk of Asthma Exacerbations in Teens With Obesity
Adolescents with overweight or obesity and asthma taking a GLP-1 agent had less risk of asthma exacerbations compared with ...
Industry Report Examines What Consumers Are Searching For After Seeing Weight Loss Patch Ads, What These Products Actually ...
Novo Nordisk plans to quickly launch the pill form of Wegovy but is expected to soon face competition from Eli Lilly.
The Brighterside of News on MSN
GLP-1 drugs like Ozempic and Wegovy are changing the foods Americans buy
The impact of popular U.S. weight-loss drugs like Ozempic and Wegovy (GLP-1 receptor agonists), upon their initial introduction to Americans, is showing many effects beyond just improving personal ...
At the end of the day, GLP-1s can be a powerful tool for achieving your weight loss goals, but only if they're safe and ...
A growing body of research suggests that older adults are discontinuing GLP-1 medications at high rates, The New York Times reported Dec. 21. Six things to know: 1. Sixty percent of Americans over age ...
ITHACA, NY. — The impact of GLP-1 medications on consumer food spending is meaningful, according to new research published by ...
Researchers are studying whether these widely used weight-loss drugs may also be future treatments for alcohol abuse.
Expanded use of GLP-1 drugs may lead to more side effects, already the subject of thousands of lawsuits now moving through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results